Stock Market

DRL stock slips 5% after US court order

   Download Android App    Share in      FullScreen   CheckVideos

Shares of Dr Reddy's Labs plunged over 5 per cent on Wednesday afternoon after a US appeals court barred the drugmaker from launching a copycat version of its rival Indivior's opioid treatment Suboxone Film. The latest hurdle comes three weeks after the US Court of Appeals for the Federal Circuit lifted a preliminary injunction that blocked it from selling Suboxone Film, saying a lower court judge erred in granting the request. The scrip was 5.30 per cent down at Rs 2,565.60 at around 02.12 pm while the benchmark Sensex rose 1.24 per cent to 35,586.20.

It opened at Rs 2,679 on the BSE against its previous closing of Rs 2,709.20.




Unlimited Portal Access + Monthly Magazine - 12 issues-Publication from Jan 2021

Buy Our Merchandise (Peace Series)

 

Contribute US to Start Broadcasting


It's Voluntary! Take care of your Family, Friends and People around You First and later think about us. Its Fine if you dont wish to contribute and if you wish to contribute then think about the Homeless first and Feed them. We can survive with your wishes too :-). You can Buy our Merchandise too which are of the finest quality.

Debit/Credit/UPI

UPI/Debit/Credit

Paytm

STRIPE

Details
Category: Stock Market


21